Search

everythinglearnresearchcommunity

for

Search:↓

ALRN-6924 may prevent hair loss caused by chemotherapy.

Upadacitinib can effectively regrow hair in alopecia areata patients without worsening sarcoidosis.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Both azathioprine and betamethasone treatments help with hair regrowth in alopecia areata, but azathioprine may have fewer side effects.

Combining DPCP with PRP doesn't improve hair regrowth in alopecia areata.

Alpha-blockers and 5-alpha reductase inhibitors don't significantly increase dementia risk.

Valproate can cause hair problems, but there are ways to manage them.

Ritlecitinib is more effective and cheaper than baricitinib for treating severe alopecia areata.

JAK inhibitors may become the first approved treatment for alopecia areata if they are proven safe and effective.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

20(S)-Protopanaxadiol-aglycone may help prevent and treat prostate cancer by reducing androgen receptor activity.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Cyproterone acetate is a safe treatment that causes mild feminizing effects in adolescent trans-girls.

Allopregnanolone and opioids together reduce stress hormone responses during pregnancy.

Switching from infliximab to Ustekinumab improved both hair loss and Crohn's symptoms in the patient.

A 12-year-old boy with PAIS successfully developed male characteristics using high-dose testosterone and anastrozole.

Ritlecitinib may cause severe musculoskeletal pain in some alopecia universalis patients.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Etanercept improved arthritis and psoriasis but caused hair loss, which healed after switching to sulfasalazine.

Baricitinib is effective for severe alopecia areata but has some side effects.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Taking 5 alpha reductase inhibitor medication slightly increases the risk of depression, especially as you get older.

Upadacitinib effectively treats pyoderma gangrenosum.

Stopping imipramine reduced the woman's hair loss.